US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.7110
  • -0.0139-1.92%
Close May 28 16:00 ET
  • 0.7200
  • +0.0090+1.27%
Pre 08:00 ET
1.50MMarket Cap-49P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
100.02%3.3M
-22.46%16.94M
91.29%5.93M
-20.74%6.12M
-45.13%3.24M
-67.78%1.65M
81.66%21.85M
-24.74%3.1M
137.41%7.72M
156.08%5.9M
Selling and administrative expenses
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
216.46%4.91M
33.01%2.65M
-General and administrative expense
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
216.46%4.91M
33.01%2.65M
Research and development costs
30.56%1.61M
-52.45%5.12M
-19.30%1.1M
-46.68%1.5M
-60.39%1.29M
-63.02%1.24M
122.41%10.76M
-22.39%1.36M
65.18%2.81M
929.32%3.26M
Operating profit
-100.02%-3.3M
22.46%-16.94M
-91.29%-5.93M
20.74%-6.12M
45.13%-3.24M
67.78%-1.65M
-81.66%-21.85M
24.74%-3.1M
-137.41%-7.72M
-156.08%-5.9M
Net non-operating interest income expense
Other net income (expense)
-37.15%82.03K
800.29%1.75M
1,093.69%1.37M
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
605.45%19.37K
Special income (charges)
----
--1.25M
----
----
----
----
----
----
----
----
-Less:Other special charges
----
---1.25M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-37.15%82.03K
157.33%500.28K
6.45%122.39K
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
605.45%19.37K
Income before tax
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
Net income continuous Operations
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
Minority interest income
Net income attributable to the parent company
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
Basic earnings per share
-111.54%-2.75
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.00%-2.7
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
-6.38%-5
Diluted earnings per share
-111.54%-2.75
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.00%-2.7
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
-6.38%-5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 100.02%3.3M-22.46%16.94M91.29%5.93M-20.74%6.12M-45.13%3.24M-67.78%1.65M81.66%21.85M-24.74%3.1M137.41%7.72M156.08%5.9M
Selling and administrative expenses 306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M216.46%4.91M33.01%2.65M
-General and administrative expense 306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M216.46%4.91M33.01%2.65M
Research and development costs 30.56%1.61M-52.45%5.12M-19.30%1.1M-46.68%1.5M-60.39%1.29M-63.02%1.24M122.41%10.76M-22.39%1.36M65.18%2.81M929.32%3.26M
Operating profit -100.02%-3.3M22.46%-16.94M-91.29%-5.93M20.74%-6.12M45.13%-3.24M67.78%-1.65M-81.66%-21.85M24.74%-3.1M-137.41%-7.72M-156.08%-5.9M
Net non-operating interest income expense
Other net income (expense) -37.15%82.03K800.29%1.75M1,093.69%1.37M64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K16.42%73.25K605.45%19.37K
Special income (charges) ------1.25M--------------------------------
-Less:Other special charges -------1.25M--------------------------------
Other non- operating income (expenses) -37.15%82.03K157.33%500.28K6.45%122.39K64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K16.42%73.25K605.45%19.37K
Income before tax -111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M
Income tax 0000000000
Net income -111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M
Net income continuous Operations -111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M
Minority interest income
Net income attributable to the parent company -111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M
Basic earnings per share -111.54%-2.7529.85%-12.97-49.42%-3.8721.54%-5.146.00%-2.770.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5-6.38%-5
Diluted earnings per share -111.54%-2.7529.85%-12.97-49.42%-3.8721.54%-5.146.00%-2.770.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5-6.38%-5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg